Radiation doses to mediastinal organs at risk in early-stage unfavorable Hodgkin lymphoma– a risk stratified analysis of the GHSG HD17 trial

INTRODUCTION: The German Hodgkin Study Group (GHSG) HD17 trial established the omission of radiotherapy (RT) for patients with early-stage unfavorable Hodgkin lymphoma being PET-negative after 2 cycles of BEACOPP escalated plus 2 cycles of ABVD. This patient group reveals heterogeneity in characteri...

Descripción completa

Detalles Bibliográficos
Autores principales: Oertel, Michael, Hering, Dominik, Baues, Christian, Kittel, Christopher, Fuchs, Michael, Kriz, Jan, Kröger, Kai, Vordermark, Dirk, Herfarth, Klaus, Engenhart-Cabillic, Rita, Lukas, Peter, Haverkamp, Uwe, Borchmann, Peter, Eich, Hans Theodor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196378/
https://www.ncbi.nlm.nih.gov/pubmed/37213291
http://dx.doi.org/10.3389/fonc.2023.1183906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196378/
https://www.ncbi.nlm.nih.gov/pubmed/37213291
http://dx.doi.org/10.3389/fonc.2023.1183906

Ejemplares similares